Orally Administered Recombinant Human Interleukin‐11 Is Protective in Experimental Neutropenic Sepsis
Steven M. Opal(Brown University), Vasu Maganti(Inflammation Research Foundation), Jhung Jhung, John E. Palardy(Brown University), James C. Keith(Women's Health Research Institute), Nicolas A. Parejo(Brown University), Erik Marchese(Inflammation Research Foundation)
Cited by 25
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k